SCP Vitalife Partners (Israel) II, L.P. is 10% Owner at Recro Pharma, Inc. (REPH). They have made 13 open-market trades across 2 companies since 2015, most recently 2020-12-22.
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 13 sales. Too few scored purchases to measure a record yet.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 77% | 38% | 62% |
| Avg Move | -0.6% | +2.5% | -6.1% |
| Scored | 13 | 13 | 13 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| REPH | SELL | 2020-12-22 | 2020-12-28 | $3.17 | $119K | -0.3% | +5.3% | -6.7% |
| REPH | SELL | 2020-12-18 | 2020-12-22 | $3.03 | $19K | -5.8% | +12.8% | +12.5% |
| REPH | SELL · 10b5-1 | 2018-01-04 | 2018-01-08 | $8.84 | $14K | +3.1% | -6.7% | +20.6% |
| REPH | SELL | 2018-01-02 | 2018-01-04 | $8.88 | $230K | +1.3% | -9.1% | +25.0% |
| REPH | SELL · 10b5-1 | 2017-12-28 | 2018-01-02 | $9.27 | $56K | -1.3% | -3.3% | +20.4% |
| REPH | SELL · 10b5-1 | 2017-12-26 | 2017-12-28 | $9.56 | $42K | -8.6% | -7.7% | +13.7% |
| REPH | SELL | 2017-03-15 | 2017-03-16 | $8.01 | $51K | -1.1% | +0.4% | -22.2% |
| REPH | SELL | 2017-03-14 | 2017-03-16 | $8.00 | $240K | -1.1% | +0.4% | -22.2% |
| REPH | SELL · 10b5-1 | 2017-02-17 | 2017-02-21 | $7.59 | $25K | -0.4% | +3.5% | +11.0% |
| REPH | SELL | 2017-02-14 | 2017-02-17 | $7.89 | $47K | -3.4% | +2.7% | +8.1% |
| REPH | SELL · 10b5-1 | 2017-02-13 | 2017-02-15 | $7.97 | $21K | -1.5% | +1.9% | +7.1% |
| RWLK | SELL | 2016-08-15 | 2016-08-17 | $6.37 | $159K | -6.3% | -6.5% | -55.1% |
| REPH | SELL | 2016-05-23 | 2016-05-25 | $6.30 | $16K | +11.2% | +3.0% | +27.5% |
| REPH | SELL | 2016-05-19 | 2016-05-23 | $6.45 | $40K | +33.3% | +24.5% | +35.2% |
| RWLK | SELL | 2016-01-15 | 2016-01-20 | $10.30 | $258K | -5.5% | +3.7% | -6.5% |
| REPH | SELL | 2015-11-30 | 2015-12-01 | $9.00 | $1K | -10.2% | -1.5% | -24.3% |
| REPH | SELL | 2015-11-25 | 2015-11-30 | $9.00 | $34K | -10.2% | -1.5% | -24.3% |
| REPH | SELL | 2015-11-23 | 2015-11-25 | $9.00 | $40K | -10.2% | -1.5% | -26.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.